NRC vs OMCL
NRC: NRC Health is an AI-powered healthcare experience management platform that helps health systems understand and act on patient, consumer, and employee feedback to improve operations and outcomes. OMCL: Omnicell automates medication management across healthcare settings through storage, dispensing, and intelligence solutions to enable safer, more efficient pharmacy operations.
Side-by-side fundamentals
| Metric | NRC | OMCL | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $21.59 | $40.86 | |
| Market cap as of 2026-07-23 | $487M | $1.9B | |
| P/E as of 2026-07-23 | 53.85 | 91.01 | NRC lower |
| PEG as of 2026-07-23 | n/a | 2.94 | |
| Net margin as of 2026-07-23 | +6.5% | +1.7% | NRC higher |
| Gross margin as of 2026-07-23 | +61.8% | +43.5% | NRC higher |
| Operating margin as of 2026-07-23 | +14.1% | +2.8% | NRC higher |
| ROE as of 2026-07-23 | +57.3% | +1.6% | NRC higher |
| ROA as of 2026-07-23 | +6.6% | +1.0% | NRC higher |
| Debt / equity as of 2026-07-23 | 5.78 | 0.13 | OMCL lower |
| Revenue growth (YoY) as of 2026-07-23 | -1.9% | +7.9% | OMCL higher |
| Revenue CAGR (3y) SEC XBRL | -3.2% | -2.9% | OMCL higher |
| Dividend yield as of 2026-07-23 | +3.0% | n/a | |
| Dividend streak (yrs) SEC XBRL | 2 | n/a | |
| Beta as of 2026-07-23 | 0.36 | 0.97 | |
| 1-year return as of 2026-07-22 close | +52.5% | +44.6% | NRC higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.